Urinary bladder carcinogenesis by DNA reactive and non-reactive chemicals: Non-linearities and thresholds

Genes and Environment

Volumn 34, Issue 4, 2012, Pages 165-170

  Cohen, Samuel M ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Acetylaminofluorene; Arsenic; Melamine; PPAR agonists; Saccharin; Urinary bladder

Indexed keywords

AFLATOXIN; ARSENIC DERIVATIVE; ASCORBIC ACID; CACODYLIC ACID; CALCIUM PHOSPHATE; CARCINOGEN; CHEMICAL AGENT; MELAMINE; N (2 FLUORENYL)ACETAMIDE; ORGANOARSENIC DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; SACCHARIN SODIUM; THIOL DERIVATIVE; TRIMETHYLARSINIC OXIDE; UNCLASSIFIED DRUG;

BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER RISK; CARCINOGENICITY; CELL PROLIFERATION; CHEMICAL INTERACTION; CRYSTALLURIA; CYTOPATHOGENIC EFFECT; DNA ADDUCT; DNA DAMAGE; DNA REPLICATION; GENOTOXICITY; HUMAN; METABOLITE; NONHUMAN; REVIEW; UROLITHIASIS;

EID: 84871739708     PISSN: 18807046     EISSN: 18807062     Source Type: Journal    
DOI: 10.3123/jemsge.34.165     Document Type: Review

References (30)

1. U.S. National Academy of Sciences. Biological effects of atomic radiation. Washington, DC: 1956.
2. Miller JA, Miller EC. Ultimate chemical carcinogens as reactive mutagenic electrophiles. In: Hiatt, editor. Origins of Human Cancer. Cold Spring Harbor Laboratory, Cold Spring Harbor; 1977. p. 605-27.
3. Calabrese EJ. Key studies used to support cancer risk assessment questioned. Environ Mol Mutagen. 2011; 52: 595-606.
4. Cohen SM, Ellwein LB. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res. 1991; 51: 6493-505.
5. Cohen SM, Arnold LL. Chemical carcinogenesis. Toxicol Sci. 2011; 120: 76-92.
6. Kensler TW, Roebuck BD, Wogan GN, Groopman JD. Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. Toxicol Sci. 2011; 120 Suppl 1: S28-48.
7. Chu FS. Mycotoxins: food contamination, mechanism, carcinogenic potential and preventive measures. Mutat Res. 1991; 259: 291-306.
8. Cohen SM, Ellwein LB. Proliferative and genotoxic cellular effects in 2-acetylaminofluorene bladder and liver carcinogenesis: biological modeling of the ED 01 study. Toxicol Appl Pharmacol. 1990; 104: 79-93. (Pubitemid 20186901)
9. Moolgavkar SH, Knudson AG Jr. Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst. 1981; 66: 1037-52. (Pubitemid 11063900)
10. Crump KS. Use of threshold and mode of action in risk assessment. Crit Rev Toxicol. 2011; 41: 637-50.
11. Greenfield RE, Ellwein LB, Cohen SM. A general probabilistic model of carcinogenesis: analysis of experimental urinary bladder cancer. Carcinogenesis. 1984; 5: 437-45. (Pubitemid 14126706)
12. Parkinson A, Ogilvie BW. Biotransformation of xenobiotics. In: Klaassen C. editor. Toxicology the Basic Science of Poisons. New York: The McGraw-Hill Companies, Inc.; 2008. p. 161-304.
13. Zeiger E. History and rationale of genetic toxicity testing: an impersonal, and sometimes personal, view. Environ Mol Mutagen. 2004; 44: 363-71. (Pubitemid 40136602)
14. Gocke E, Muller L. In vivo studies in the mouse to define a threshold for the genotoxicity of EMS and ENU. Mutat Res. 2009; 678: 101-7.
15. Farmer JH, Kodell RL, Greenman DL, Shaw GW. Dose and time response models for the incidence of bladder and liver neoplasms in mice fed 2-acetylaminofluorene continuously. J Environ Pathol Toxicol. 1979; 3: 55-68.
16. Beland FA, Fullerton NF, Kinouchi T, Smith BA, Poirier MC. DNA adduct formation in relation to tumorigenesis in mice chronically fed 2-acetylaminofluorene. Prog Clin Biol Res. 1990; 331: 121-9.
17. Cohen SM, Ohnishi T, Arnold LL, Le XC. Arsenic-induced bladder cancer in an animal model. Toxicol App Pharmacol. 2007; 222: 258-63. (Pubitemid 47198272)
18. Cohen SM, Arnold LL, Eldan M, Schoen AS, Beck BD. Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit Rev Toxicol. 2006; 36: 99-133.
19. Suzuki S, Arnold LL, Ohnishi T, Cohen SM. Effects of inorganic arsenic on the rat and mouse urinary bladder. Toxicol Sci. 2008; 106: 350-63.
20. Mink PJ, Alexander DD, Barraj LM, Kelsh MA, Tsuji JS. Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis. Regul Toxicol Pharmacol. 2008; 52: 299-310.
21. Lamm SH, Engel A, Penn CA, Chen R, Feinleib M. Arsenic cancer risk confounder in southwest Taiwan data set. Environ Health Perspect. 2006; 114: 1077-82. (Pubitemid 44018906)
22. Cohen SM, Johansson SL, Arnold LL, Lawson TA. Urinary tract calculi and thresholds in carcinogenesis. Food Chem Toxicol. 2002; 40: 793-99. (Pubitemid 34450775)
23. Clayson DB, Fishbei, L, Cohen SM. The effect of stones and other physical factors on the induction of rodent bladder cancer. Food Chem Toxicol. 1995; 33: 771-84.
24. IARC Working Group. Consensus Report. International Agency for Research on Cancer, IARC Scientific Publications, 1999; 147: 1-32.
25. Dominick MA, White MR, Sanderson T, Van Vleet TR, Cohen SM, Arnold LL, Cano M, Tannehill-Gregg S, Moehlenkamp JD, Waites CR, Schilling BE. Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR a/ g agonist: evidence for urolithiasis as the inciting event in the mode of action. Toxicol Pathol. 2006; 34: 903-20. (Pubitemid 46011143)
26. Meek ME, Bucher JR, Cohen SM, Dellarco V, Hill RN, Lehman-McKeeman LD, Longfellow DG, Pastoor T, Seed J, Patton DE. A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol. 2003; 33: 591-653. (Pubitemid 38040084)
27. Wang IJ, Chen PC, KC Huang. Melamine and nephrolithiasis in children in Taiwan. N Engl J Med. 2009; 360: 1157-8.
28. Cohen SM. Calcium phosphate-containing urinary precipitate in rat urinary bladder carcinogenesis. International Agency for Research on Cancer, IARC Scientific Publications. 1999; 147: 175-89.
29. Cohen SM. Urinary bladder carcinogenesis. Toxicol Pathol. 1998; 26: 121-7. (Pubitemid 28100696)
30. Cohen SM. Effects of PPAR g and combined agonists on the urinary tract of rats and other species. Toxicol Sci. 2005; 87: 322-7. (Pubitemid 41300679)